Global Remodeling of the Vascular Stem Cell Niche in Bone Marrow of Diabetic Patients: Implication of the microRNA-155/FOXO3a Signaling Pathway

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation Research

• Publication date

  2012-12-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.112.300598PMID 23250986PMCID PMC3616365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Legionella Kinase LegK2 Targets the ARP2/3 Complex To Inhibit Actin Nucleation on Phagosomes and Allow Bacterial Evasion of the Late Endocytic Pathway

  2015cited by this paper
• Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans

  2013cited by this paper
• Role for Substance P–Based Nociceptive Signaling in Progenitor Cell Activation and Angiogenesis During Ischemia in Mice and in Human Subjects

  2012cited by this paper
• Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow, and spleen.

  2012cited by this paper
• Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy

  2012cited by this paper
• Role of microRNAs in diabetes and its cardiovascular complications

  2011cited by this paper
• miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg

  2011cited by this paper
• Diabetic stem-cell "mobilopathy".

  2011cited by this paper
• Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer

  2011cited by this paper
• Tissue Kallikrein Is Essential for Invasive Capacity of Circulating Proangiogenic Cells

  2011cited by this paper
• One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction

  2011cited by this paper
• CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

  2011cited by this paper
• MicroRNA regulation in angiogenesis.

  2011cited by this paper
• Diabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function

  2011cited by this paper
• Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

  2010cited by this paper
• Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis

  2010cited by this paper
• Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol

  2010cited by this paper
• CD31+ Cells Represent Highly Angiogenic and Vasculogenic Cells in Bone Marrow: Novel Role of Nonendothelial CD31+ Cells in Neovascularization and Their Therapeutic Effects on Ischemic Vascular Disease

  2010cited by this paper
• Circulating MicroRNAs in Patients With Coronary Artery Disease

  2010cited by this paper
• Diabetes Mellitus Induces Bone Marrow Microangiopathy

  2010cited by this paper
• MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output

  2010cited by this paper
• Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice

  2010cited by this paper
• Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells.

  2010cited by this paper
• microRNA: emerging therapeutic targets in acute ischemic diseases.

  2010cited by this paper
• FOXO Transcription Factors Enforce Cell Cycle Checkpoints and Promote Survival of Hematopoietic Cells after DNA Damage

  2009cited by this paper
• Human CD133+ Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling

  2009cited by this paper
• Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock

  2009cited by this paper
• Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

  2009cited by this paper
• Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment

  2009cited by this paper
• Faculty Opinions recommendation of Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

  2008cited by this paper
• Role of Kinin B2 Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.

  2008cited by this paper
• AMD3100 and Granulocyte Colony Stimulating Factor (G-CSF) Mobilize Different CD34+ Cell Populations Based on Global Gene and Micro RNA Expression.

  2008cited by this paper
• Assessing identity, phenotype, and fate of endothelial progenitor cells.

  2008cited by this paper
• Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

  2008cited by this paper
• Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis.

  2007cited by this paper
• Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.

  2007cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients

  2007cited by this paper
• CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities

  2006cited by this paper
• Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.

  2006cited by this paper
• CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control

  2006influential reference
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety

  2005cited by this paper
• Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells

  2005cited by this paper
• Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

  2005cited by this paper
• T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer

  2005cited by this paper
• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

  2004cited by this paper
• Heart infarct in NOD‐SCID mice: Therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells

  2004cited by this paper
• Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis

  2004cited by this paper
• Bmi1, stem cells, and senescence regulation.

  2004cited by this paper
• MicroRNAs Modulate Hematopoietic Lineage Differentiation

  2004cited by this paper
• Transplantation of low dose CD34+Kdr+ cells promotes vascular and muscular regeneration in ischemic limbs

  2004cited by this paper
• What is known

  2003cited by this paper
• The Forkhead Transcription Factor FoxO Regulates Transcription of p27Kip1 and Bim in Response to IL-21

  2002cited by this paper
• Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

  2002cited by this paper
• Identification of the hemangioblast in postnatal life.

  2002cited by this paper
• Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures

  2002cited by this paper
• Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

  2000influential reference
• Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7.

  2000cited by this paper
• The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry

  1996cited by this paper

• Resilient Calvarial Bone Marrow Supports Retinal Repair in Type 2 Diabetes

  2026cites this paper
• Function of hematopoiesis and bone marrow niche in inflammation and non-hematopoietic diseases

  2025cites this paper
• Type 2 diabetes Reprograms Bone Marrow Hematopoiesis and Dysregulates Immune Signaling in Response to Stroke

  2025cites this paper
• Macromolecular Crowding Supports the Generation of Basal Membrane-Rich Pericyte-Based Cell Sheets Useful for Cell Therapy of Diabetic Wounds

  2025cites this paper
• Decreased PECAM-1 May be a potential pathological factor for vascular injury in T2DM patients

  2025cites this paper
• Clinical implications of bone marrow adiposity identified by phenome-wide association and Mendelian randomization in the UK Biobank

  2025influential citation
• Murine limb ischaemia induces structural and functional remodelling of local and distant bone marrow

  2025cites this paper
• The Broken Cradle: Bone Marrow Stem Cell Niche Remodelling in Diabetes

  2025influential citation
• Prolonged DEHP exposure enhances the stemness and metastatic potential of TNBC cells in an MSI2-dependent manner

  2025cites this paper
• Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

  2025cites this paper
• Diabetes and the Microvasculature of the Bone and Marrow

  2024cites this paper
• The long-chain polyfluorinated alkyl substance perfluorohexane sulfonate (PFHxS) promotes bone marrow adipogenesis.

  2024cites this paper
• Adiposity and Mineral Balance in Chronic Kidney Disease

  2024cites this paper
• MicroRNAs in the progression of atherosclerosis: rise and fall of the atherosclerotic plaque

  2024cites this paper
• Function and Regulation of Bone Marrow Adipose Tissue in Health and Disease: State of the Field and Clinical Considerations.

  2024cites this paper
• Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.

  2024cites this paper
• Vascular deficits contributing to skeletal fragility in type 1 diabetes

  2023cites this paper
• Effect of Apitoxin on Alveolar Bone Alterations in Induced Diabetic Rats (An Animal Study)

  2023cites this paper
• The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies

  2023cites this paper
• Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves

  2023cites this paper
• Pathological roles of bone marrow adipocyte-derived monocyte chemotactic protein-1 in type 2 diabetic mice

  2023cites this paper
• Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications

  2023cites this paper
• Endothelial heterogeneity and their relevance in cardiac development and coronary artery disease.

  2023cites this paper
• Bone marrow vasculature advanced in vitro models for cancer and cardiovascular research

  2023cites this paper
• Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

  2023cites this paper
• Bone Marrow as a Therapeutic Target for Type 2 Diabetes Complications.

  2023cites this paper
• A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia

  2023cites this paper
• TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a

  2022cites this paper
• Angiocrine endothelium: From physiology to atherosclerosis and cardiac repair.

  2022cites this paper
• Unraveling and Targeting Myocardial Regeneration Deficit in Diabetes

  2022cites this paper
• Circulating progenitor cells and outcomes in patients with coronary artery disease.

  2022cites this paper
• A cohort study of circulating progenitor cells after ST-segment elevation and non-ST segment elevation myocardial infarction in non-diabetic and diabetic patients

  2022cites this paper
• When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors

  2022cites this paper
• Dysregulated transforming growth factor-beta mediates early bone marrow dysfunction in diabetes

  2022cites this paper
• Dysfunction of macrophages leads to diabetic bone regeneration deficiency

  2022cites this paper
• Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers

  2022cites this paper
• Neuritin Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration to Treat Diabetic Peripheral Neuropathy

  2022cites this paper
• Hematopoietic progenitor cell liabilities and alarmins S100A8/A9‐related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults

  2022influential citation
• Hematopoietic Progenitors and the Bone Marrow Niche Shape the Inflammatory Response and Contribute to Chronic Disease

  2022cites this paper
• Phase I/IIa Feasibility Trial of Autologous Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Non-Healing Extremity Ulcers

  2022cites this paper
• Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes

  2022cites this paper
• The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications

  2021cites this paper
• Mobilization of endothelial progenitor cells promotes angiogenesis after full thickness excision by AMD3100 combined with G-CSF in diabetic mice by SDF-1/CXCR4 axis

  2021cites this paper
• Experimental Type 2 Diabetes Differently Impacts on the Select Functions of Bone Marrow-Derived Multipotent Stromal Cells

  2021cites this paper
• Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy

  2021cites this paper
• (Accepted/In press). Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy. Current diabetes reports.

  2021cites this paper
• Efficiency of mesenchymal stromal cells (MSCs) in the treatment of patients with critical limb-threatening ischemia

  2021cites this paper
• Carbon black nanoparticles induce pulmonary fibrosis through NLRP3 inflammasome pathway modulated by miR-96 targeted FOXO3a.

  2020cites this paper
• P. R. (2020). MicroRNA-21/PDCD4 proapoptotic signaling from circulating CD34+ cells to vascular endothelial cells: a potential contributor to adverse cardiovascular outcomes in patients with critical limb ischemia

  2020cites this paper
• Effects of zoledronic acid combined with metformin on bones of DB/DB mice

  2020cites this paper
• Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.

  2020cites this paper
• Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction

  2020cites this paper
• Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept

  2020cites this paper
• Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial

  2020cites this paper
• MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34+ Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia

  2020cites this paper
• Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes

  2020cites this paper
• Bone marrow fat: friend or foe in people with diabetes mellitus?

  2020cites this paper
• MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia

  2020cites this paper
• Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus

  2020cites this paper
• Bone Marrow Adipose Tissue

  2020cites this paper
• Bone marrow pericyte dysfunction in individuals with type 2 diabetes

  2019cites this paper
• ATVB IN FOCUS: Peripheral Artery Disease

  2019cites this paper
• Diabetes-Associated Myelopoiesis Drives Stem Cell Mobilopathy Through an OSM-p66Shc Signaling Pathway

  2019cites this paper
• Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects.

  2019cites this paper
• MCP-1 Feedback Loop Between Adipocytes and Mesenchymal Stromal Cells Causes Fat Accumulation and Contributes to Hematopoietic Stem Cell Rarefaction in the Bone Marrow of Patients With Diabetes. Diabetes , 67 (7), 1380-1394.

  2019cites this paper
• The sodium-hydrogen antiporter: a new target to boost post-ischemic angiogenesis in diabetes?

  2019cites this paper
• Bone marrow as a target and accomplice of vascular complications in diabetes

  2019cites this paper
• Impact of Diabetes Mellitus on Bone Health

  2019cites this paper
• Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties

  2019cites this paper
• Circulating microRNA-155 is associated with insulin resistance in chronic hepatitis C patients.

  2019cites this paper
• Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives

  2019cites this paper
• MicroRNA-93 regulates angiogenesis in peripheral arterial disease by targeting CDKN1A

  2019cites this paper
• Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia

  2019cites this paper
• Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus.

  2019cites this paper
• Endothelial Regenerative Capacity and Aging: Influence of Diet, Exercise and Obesity

  2018cites this paper
• Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow

  2018cites this paper
• MCP-1 Feedback Loop Between Adipocytes and Mesenchymal Stromal Cells Causes Fat Accumulation and Contributes to Hematopoietic Stem Cell Rarefaction in the Bone Marrow of Patients With Diabetes

  2018cites this paper
• Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR‐pQCT Study

  2018cites this paper
• Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation

  2018cites this paper
• Pharmacologic targeting of the diabetic stem cell mobilopathy

  2018cites this paper
• Neuropathy and inflammation in diabetic bone marrow

  2018cites this paper
• Diabetics show accelerated progression of knee cartilage and meniscal lesions: data from the osteoarthritis initiative

  2018cites this paper
• Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential

  2018cites this paper
• Water extract of Brazilian green propolis attenuates high glucose-induced vascular morphological abnormality in zebrafish

  2018cites this paper
• Circulation Research “In This Issue” Anthology

  2018cites this paper
• Pericytes, integral components of adult hematopoietic stem cell niches

  2017cites this paper
• Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.

  2017cites this paper
• Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes

  2017cites this paper
• Posttranscriptional regulation of FOXO expression: microRNAs and beyond

  2017cites this paper
• Autologous Bone Marrow-Derived Stem Cells for Treating Diabetic Neuropathy in Metabolic Syndrome

  2017cites this paper
• MicroRNAs in Diabetes and Its Vascular Complications

  2017cites this paper
• Overexpression of miR-155 in clear-cell renal cell carcinoma and its oncogenic effect through targeting FOXO3a

  2017cites this paper
• Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.

  2017cites this paper
• Is Diabetic Skeletal Fragility Associated with Microvascular Complications in Bone?

  2017cites this paper
• Non-coding RNAs in the Vasculature

  2017cites this paper
• Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy

  2017cites this paper
• Diabetes mellitus as a poor mobilizer condition.

  2017cites this paper
• Task for Today: Complete the Puzzle of Circulating Stem Cells and the Atherosclerotic Burden.

  2016cites this paper
• Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications

  2016cites this paper
• Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.

  2016cites this paper